Loading…
Bausch Health Companies Inc. is projected to rise to $7.24 by 2027, a +20% move from its current price of $6.03. BHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $5.85 | $6.03 | $6.21 | +0.02% |
| Aug 2 | $5.78 | $6.03 | $6.29 | +0.04% |
| Aug 3 | $5.73 | $6.03 | $6.35 | +0.06% |
| Aug 4 | $5.68 | $6.04 | $6.41 | +0.08% |
| Aug 5 | $5.65 | $6.04 | $6.45 | +0.10% |
| Aug 6 | $5.61 | $6.04 | $6.50 | +0.13% |
| Aug 7 | $5.58 | $6.04 | $6.54 | +0.15% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $5.58 | $6.04 | $6.54 | +0.15% |
| Week 2 | $5.41 | $6.05 | $6.76 | +0.29% |
| Week 3 | $5.28 | $6.06 | $6.95 | +0.44% |
| Week 4 | $5.18 | $6.07 | $7.11 | +0.59% |
| Week 5 | $5.09 | $6.07 | $7.25 | +0.74% |
| Week 6 | $5.01 | $6.08 | $7.38 | +0.88% |
| Week 7 | $4.94 | $6.09 | $7.51 | +1.03% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb.
The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. Bausch Health Companies Inc.
is headquartered in Laval, Canada and is categorized in Healthcare.
Bausch Health Companies Inc. (BHC) is trading at $6.03 with a market cap of $2.25B and is ranked 1828. The near-term forecast for 2026 shows a neutral stance with an average price of $6.03 and a range from $4.43 to $7.89.
A major floor 35.4% below — a decisive break under it would weaken the trend.
The nearest floor, 26.5% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 17.7% above — clearing it would confirm fresh momentum.
Key BHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.83 | Buy | $5.06 | Buy |
| MA 10 | $4.72 | Buy | $4.87 | Buy |
| MA 20 | $4.79 | Buy | $4.83 | Buy |
| MA 50 | $4.98 | Buy | $4.98 | Buy |
| MA 100 | $5.20 | Buy | $5.25 | Buy |
| MA 200 | $5.84 | Buy | $5.64 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 74.02 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 406.72 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.09 | Buy |
| ROC (12) | 26.95 | Buy |
| Bollinger %B (20,2) | 1.44 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.30 | Sell |
| Awesome (5,34) | -0.01 | Sell |
| Ultimate (7,14,28) | 83.42 | Sell |
| Momentum (10) | 1.10 | Buy |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 5.02 | Buy |
| ADX (14) | 18.37 | Neutral |
| ATR (14) | 0.19 | Info |
The 30-day technical picture is Neutral. RSI14 is 70, with a SMA50 of $4.98 and a SMA200 of $5.84. Key levels are support at $4.43 and resistance at $6.03. The 30-day range runs from $4.95 to $7.34, and annualized volatility is 60%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.43 | $6.03 | $7.89 | 0% | Neutral | |
| $5.73 | $7.24 | $9.72 | +20% | Bullish | |
| $6.15 | $8.03 | $11.22 | +33% | Bullish | |
| $5.81 | $7.79 | $11.23 | +29% | Bullish | |
| $6.36 | $8.72 | $12.90 | +45% | Bullish | |
| $7.34 | $10.27 | $15.56 | +70% | Bullish | |
| $8.48 | $12.10 | $18.70 | +101% | Bullish | |
| $9.64 | $14.00 | $22.05 | +132% | Bullish | |
| $9.13 | $13.49 | $21.61 | +124% | Bullish | |
| $9.04 | $13.58 | $22.11 | +125% | Bullish | |
| $13.51 | $21.90 | $38.08 | +263% | Bullish | |
| $24.13 | $44.64 | $85.39 | +640% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.43 | $6.03 | $7.04 | +0.00% |
| August 2026 | $5.09 | $5.98 | $7.21 | -0.76% |
| September 2026 | $5.18 | $6.15 | $7.51 | +2.71% |
| October 2026 | $5.31 | $6.35 | $7.85 | +3.30% |
| November 2026 | $5.22 | $6.28 | $7.84 | -1.10% |
| December 2026 | $5.18 | $6.27 | $7.89 | -0.22% |
Click any year to see its month-by-month BHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Bausch Health Companies Inc.'s 2026 outlook centres on $6.03, within a $4.43 to $7.89 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, BHC could reach as high as $9.72, with a base case around $7.24 and support toward $5.73 — roughly +20% from $6.03. Buyers look set to stay in control over this stretch.
Expect BHC to range from $6.15 to $11.22 through 2028. The $8.03 average target implies a +33% move from current prices. That is up +11% on the projected 2027 average. Momentum favours further upside here.
The BHC price prediction for 2029 points to an average of $7.79 (low $5.81, high $11.23) — a potential gain of +29% on today's $6.03. Buyers look set to stay in control over this stretch.
In 2030, BHC is projected to trade between $6.36 and $12.90, averaging $8.72 — a potential gain of +45% from today's $6.03. That is up +12% on the projected 2029 average. Momentum favours further upside here.
Bausch Health Companies Inc.'s 2031 outlook centres on $10.27, within a $7.34 to $15.56 range. That is up +18% on the projected 2030 average. That marks a +70% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, BHC could reach as high as $18.70, with a base case around $12.10 and support toward $8.48 — roughly +101% from $6.03. Momentum favours further upside here.
Expect BHC to range from $9.64 to $22.05 through 2033. The $14.00 average target implies a +132% move from current prices. That is up +16% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The BHC price prediction for 2034 points to an average of $13.49 (low $9.13, high $21.61) — a potential gain of +124% on today's $6.03. Momentum favours further upside here.
In 2035, BHC is projected to trade between $9.04 and $22.11, averaging $13.58 — a potential gain of +125% from today's $6.03. That is up +1% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Bausch Health Companies Inc.'s 2040 outlook centres on $21.90, within a $13.51 to $38.08 range. That is up +61% on the projected 2035 average. That marks a +263% change versus current levels. Momentum favours further upside here.
By 2050, BHC could reach as high as $85.39, with a base case around $44.64 and support toward $24.13 — roughly +640% from $6.03. Buyers look set to stay in control over this stretch.
Investing $1,000 in BHC today (≈ 165.837479 BHC) could be worth
$7,402.35
+$6,402.35 (+640%) by 2050 · US Dollar
Based on the average projected BHC price of $44.64 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BHCwould be worth at today's price.
$1,000 invested in BHC on Jul 30, 2025 (≈ 156.494526 BHC) would be worth
$943.66
-$56.34 (-5.6%) today · 0.94× · US Dollar
Based on a BHC entry price of $6.39 vs. today's $6.03.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.45 | $1,355.06 | +35.5% |
| 1 month ago | $4.93 | $1,223.12 | +22.3% |
| 3 months ago | $5.65 | $1,067.26 | +6.7% |
| 6 months ago | $5.74 | $1,050.52 | +5.1% |
| 1 year ago | $6.39 | $943.66 | -5.6% |
| All time (5.0y) ago | $29.65 | $203.37 | -79.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BHC forecast.
Our base-case forecast reaches $12.00 around 2032.
Implied market cap at $12.00: $4.48B
Long-term forecasts are bullish from 2027 onward. The 2026 forecast shows an avg of $6.03 with a neutral sentiment, while 2027 shows an avg of $7.24 and 2028 $8.03, with increasing upside through 2029 ($7.79) and 2030 ($8.72; ROI 44.5%). The 2031 forecast is an avg of $10.27 (ROI 70.3%), 2032 is $12.10 (ROI 100.6%), and 2033 is $14.00 (ROI 132.1%).
The path continues to 2034 at $13.49 (ROI 123.7%) and 2035 at $13.58 (ROI 125.2%). By 2040 the avg reaches $21.90 (ROI 263.2%), and by 2050 the avg is $44.64 with a large upside (ROI 640.2%), all under a bullish sentiment. These are estimates, not guarantees, and reflect the sustained longer-term upside implied by the forecast.
Tap a question to reveal the answer.
2030 forecast: min $6.36, avg $8.72, max $12.90; ROI 44.5%; sentiment BULLISH.
The forecast shows neutral sentiment in 2026 and bullish sentiment from 2027 onward, with rising averages and upside through 2050. These are estimates, not guarantees.
2031 forecast: min $7.34, avg $10.27, max $15.56; ROI 70.3%; sentiment BULLISH.
2040 forecast: min $13.51, avg $21.90, max $38.08; ROI 263.2%; sentiment BULLISH.
Current price is $6.03; market cap is $2.25B; rank 1828.
Bausch Health Companies Inc. Community Discussion
0Share your Bausch Health Companies Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.